weight regain after stopping semaglutide trial Trajectory of the body drug discontinuation in the treatment of anti-obesity medications | BMC Medicine Semaglutide versus placebo in individuals

With roughly two-thirds of Americans overweight, and one out of three obese, this class of drugs has understandably generated a lot of interest whether its people hailing their impact on weight loss, or voicing concerns about their side effects

This maintenance phase begins only after the initial deficiency has been corrected and the patients blood markers have stabilized within the normal range

A recent study investigated the impact of DSIP on major depressive disorders and suicidal subjects (4)

However, if used improperly or combined with a calorie surplus, it could contribute to weight gain through increased appetite or water retention